SCHEMBL1709100

SCHEMBL1709100

CN(C)C(=O)Oc1ccc2cccnc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCEH1 Q6PIU2 2/20 0.54
RAB9A P51151 2/20 0.51
ALDH1A1 P00352 4/20 0.51
CYP3A4 P08684 1/20 0.48
GRM4 Q14833 1/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
P2RY14 Q15391 2/20 0.46
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
PDE10A Q9Y233 1/20 0.46
LMNA P02545 3/20 0.46
BCHE P06276 2/20 0.46
ACHE P22303 2/20 0.46
CA2 P00918 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
PKM P14618 2/20 0.44
NPC1 O15118 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17585031 0.88 ALDH1A1 (0.66) NCEH1RAB9AALDH1A1CYP3A4KMT2A
SCHEMBL5647416 0.85 LMNA (0.58) RAB9AALDH1A1CYP3A4KMT2AMEN1
SCHEMBL30791497 0.83 ALDH1A1 (0.55) ALDH1A1CYP3A4KMT2AMEN1P2RY14
SCHEMBL13889564 0.83 ALDH1A1 (0.55) ALDH1A1CYP3A4KMT2AMEN1P2RY14
SCHEMBL933272 0.83 CYP3A4 (0.54) RAB9AALDH1A1CYP3A4KMT2AMEN1
SCHEMBL9429741 0.82 CYP3A4 (0.48) RAB9AALDH1A1CYP3A4KMT2AMEN1
SCHEMBL933273 0.81 CYP3A4 (0.56) RAB9AALDH1A1CYP3A4KMT2AMEN1
SCHEMBL6632328 0.80 ALDH1A1 (0.51) RAB9AALDH1A1CYP3A4KMT2AMEN1
SCHEMBL27383069 0.79 CYP3A4 (0.51) RAB9AALDH1A1CYP3A4KMT2AMEN1
Naphthalen-2-Yl Dimethylcarbamate SCHEMBL16005596 0.79 NCEH1 (0.70) NCEH1RAB9AALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8691992-B2 Octahydro biquinoline compound NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-04-08 US disclosed
US-20120088916-A1 OCTAHYDRO BIQUINOLINE COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088916-A1 OCTAHYDRO BIQUINOLINE COMPOUND CYP2S1, HCRTR2, CYP2B6 NCEH1 73/4885RAB9A 2786/4885ALDH1A1 1988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.